Simone Calzolari

CEO

Barcelona, Catalonia, Spain18 yrs 5 mos experience

Most Likely To SwitchHighly Stable

Key Highlights

Leader in zebrafish-based drug discovery innovation.
Expert in developmental biology and translational science.
Founder of a pioneering cardiovascular therapeutics company.

Stackforce AI infers this person is a Biopharma expert specializing in zebrafish models for drug discovery.

Contact

Skills

Core Skills

ZebrafishBiopharma InnovationCommercial DevelopmentMarket AnalysisScientific LeadershipTechnical DevelopmentPharmaceutical InnovationDevelopmental BiologyResearch

Other Skills

Animal ModelsAssay DevelopmentCommercial StrategyCustomer ServiceScientific ManagementTechnical StrategyZebrafish ModelsCardiovascular Drug DiscoveryCellular MechanismsConfocal MicroscopyNeuroectodermal DifferentiationBiochemistryCell CultureBioinformaticsLifesciences

About

I am working at the forefront of biopharma innovation at ZeClinics, where we harness the power of zebrafish models to accelerate drug discovery and preclinical research. Passionate about innovation and translational science, I dedicate myself to bridge cutting-edge technology with meaningful healthcare solutions.

Experience

18 yrs 5 mos

Total Experience

6 yrs 3 mos

Average Tenure

12 yrs 10 mos

Current Experience

Zeclinics

3 roles

Chief Executive Officer

Promoted

Dec 2020 – Present · 5 yrs 5 mos

As ZeClinics CEO, my responsibility will be sustaining the company growth and expand its business globally. Moreover, I will contribute with my experience and knowledge to drive the company to another level in which ZeClinics will be the referent of zebrafish in the pharmaceutical sector. Our challenge we will be to bring this fantastic animal model to all the drug discovery pipelines of the world.

Animal ModelsAssay DevelopmentZebrafishBiopharma Innovation

Chief Commercial Officer

Promoted

Sep 2015 – Dec 2020 · 5 yrs 3 mos

My principal responsibility is directing the Commercial Department at ZeClinics. I am in charge of finding new commercial opportunities, generating potential leads, translating market needs or trends to technical department and finally providing customer services.

Commercial StrategyCustomer ServiceCommercial DevelopmentMarket Analysis

CTO

Jun 2013 – Aug 2015 · 2 yrs 2 mos

ZeClinics is a start-up CRO, founded in June 2013. We provide our expertise in the use of zebrafish to pharmaceutical and biotech companies to innovate the preclinical phase of drug discovery. We offer assays of general and organo-specific toxicity and efficacy in the fields of oncology and neural disorders. Besides our interest in pharma industry services, ZeClinics establish partnerships with academic groups interested in using zebrafish in their research & development.
As ZeClinics CTO I am in charge of the scientific and technological issues of the company. I closely follow the portfolio of experimental assays that ZeClinics offers and the new technical strategies that the company undertakes.

Scientific ManagementTechnical StrategyScientific LeadershipTechnical Development

Zecardio therapeutics

Co-founder Chairman Of The Board

Jul 2019 – Present · 6 yrs 10 mos · Greater Barcelona Metropolitan Area

ZeCardio Therapeutics (ZeCardioTx) is a pharma company that will change the way we discover cardiovascular drugs. To do so, ZeCardioTx profits from using the zebrafish model and an innovative, proprietary screening and analysis platform, ZeCardio®, which allows the effective, cost-efficient and rapid discovery of therapeutic molecules.

Zebrafish ModelsCardiovascular Drug DiscoveryZebrafishPharmaceutical Innovation

Universitat pompeu fabra

PhD student in Biomedicine

Nov 2008 – Oct 2013 · 4 yrs 11 mos

My PhD was focused in developmental biology. Using zebrafish animal model I studied the cellular and molecular mechanisms involved in the segregation of cellular populations that belong to the hindbrain, that is the third vesicle of the brain.
I combined classical in vitro approaches with the most modern advances in the confocal microscopy that nowadays allow us to observe what happens inside every single cell during time.
My results made step forward in the field of basic developmental biology and confirm again that exists a link between gene regulation and the biomechanics in morphogenetic processes and importantly that many more mechanisms than expected are conserved between vertebrates and flies.
Part of this work was accepted for publication in EMBO journal. In the last part of thesis I performed also other experiments that are now ready to be published. The work was presented in different national and international meetings: in the European Zebrafish Meeting 2013, in the International Zebrafish development meeting 2012, Barcelona Developmental Biology Joint Retreat 2011, EMBO frontiers in sensory and Development 2011.

Developmental BiologyCellular MechanismsResearch